Journal of Cardiovascular Pharmacology and Therapeutics

Aims & Scope

Journal of Cardiovascular Pharmacology and Therapeutics is a peer-reviewed journal that publishes original clinical research focused on new and emerging therapies for cardiovascular diseases, and original preclinical research with clear translational relevance.

The journal also publishes state-of-the-art review articles, commentaries and editorials, as well as selected supplements and focused issues.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,325.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Metabolic Syndrome

  Citation: 228

  Authors: Dawn Harris, Parvathi, Charles H.

• Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1

  Citation: 215

  Authors: Duncan, Claire, Lorna, Sven, James E., J. J. J.

• Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model

  Citation: 163

  Authors: J. J. J., James, Philip, Ian, Jan-Arne

• Inflammation and Atherosclerosis—Revisited

  Citation: 156

  Authors: Sadip, Abhishek, Guru S., Naga Venkata, Thomas Evans, Francesco, Jawahar L.

• Arterial Elastance and Wave Reflection Augmentation of Systolic Blood Pressure: Deleterious Effects and Implications for Therapy

  Citation: 150

  Authors: Wilmer W., David G.

• Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit

  Citation: 139

  Authors: Jacob C., James C., Christopher B., Mark

• Platelet P2Y₁₂Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts

  Citation: 135

  Authors: Xi-Ming, Yanping, Lin, Xiulan, Yongge, Narendra, Junichi, James M., Michael V.

• Cell Death Pathways in Acute Ischemia/Reperfusion Injury

  Citation: 129

  Authors: Roberta A.

• Diuretics

  Citation: 129

  Authors: George C., Ramdeep, Michael E.

• Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism

  Citation: 120

  Authors: Abdulmaged M., Ahmad, Karim Sultan, Gheorghe, Farid